the immune system's role in higher-risk mds
Published 2 years ago • 249 plays • Length 6:05Download video MP4
Download video MP3
Similar videos
-
2:49
the role of the immune system in the pathophysiology of mds
-
1:32
the role of the innate immune system in mds pathogenesis
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
1:38
the role and targeting of immune dysregulation in mds
-
33:29
higher-risk mds and aml: how new guidelines are changing diagnosis, classification and management
-
4:28
understanding myelodysplastic syndromes (mds)
-
6:45
clonal hematopoiesis of indeterminate potential as a novel risk factor for stroke
-
1:48
immune therapy approaches in mds
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
2:03
molecular pathogenesis and immune dysregulation in mds
-
1:59
the role of inflammatory signaling pathways in lower-risk mds
-
2:50
magrolimab azacitidine in untreated higher-risk mds
-
2:18
immune dysregulation and clonal hematopoiesis in mds
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
1:25
prognosis and treatment in high-risk mds
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
4:44
immunotherapy in mds
-
2:07
emerging targeted treatments for mds
-
6:24
immuno-oncology approaches in mds
-
1:21
hmas for mds- a party of one